Yin and yang of cannabinoid CB1 receptor: CB1 deletion in immune cells causes exacerbation while deletion in non-immune cells attenuates obesity-Reference-Cited by-同舟云学术

Yin and yang of cannabinoid CB1 receptor: CB1 deletion in immune cells causes exacerbation while deletion in non-immune cells attenuates obesity

Published:2022-09 Issue:9 Volume:25 Page:104994
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Miranda Kathryn,Becker William,Busbee Philip B.^ORCID,Dopkins Nicholas^ORCID,Abdulla Osama A.,Zhong Yin,Zhang Jiajia,Nagarkatti Mitzi,Nagarkatti Prakash S.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference62 articles.

1. Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age;Agudo;Diabetologia,2010

2. Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability;Alhamoruni;J. Pharmacol. Exp. Ther.,2010

3. Diet-induced obesity in cannabinoid-2 receptor knockout mice and cannabinoid receptor 1/2 double-knockout mice;Alshaarawy;Obesity,2019

4. Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARalpha dependent;Azar;Mol. Metab.,2020

5. Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice;Bajzer;Diabetologia,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delta-9-Tetrahydrocannabinol Blocks Bone Marrow-Derived Macrophage Differentiation through Elimination of Reactive Oxygen Species;Antioxidants;2024-07-23

2. The progress of small molecules against cannabinoid 2 receptor (CB2R);Bioorganic Chemistry;2024-03

3. G protein-coupled receptor-biased signaling: potential drug discovery to facilitate treatment of metabolic diseases;Acta Materia Medica;2024

4. Supporting gut health with medicinal cannabis in people with advanced cancer: potential benefits and challenges;British Journal of Cancer;2023-10-26

5. Exploring the Therapeutic Potential of Cannabinoid Receptor Antagonists in Inflammation, Diabetes Mellitus, and Obesity;Biomedicines;2023-06-08